- Autologous Transplant
- Allogenic Transplant
- Others
Bone Marrow Transplant Market size was valued at USD 10.28 billion in 2023 and is poised to grow at a CAGR of 5.2% from 2024-2030. The market refers to the medical industry involved in the transplantation of healthy bone marrow cells to replace damaged or diseased bone marrow. This procedure is primarily used in the treatment of various blood disorders, cancers, and immune system disorders. A major driver is the increasing prevalence of blood-related diseases, such as leukemia and lymphoma, which require transplantation as a potentially curative treatment option. Additionally, advancements in transplantation techniques, improved compatibility testing, and the availability of better post-transplant care have contributed to the market's growth.
However, the market also faces certain challenges. The high cost associated with the procedure, including pre-transplant testing, transplantation itself, and post-transplant care, poses a significant challenge for patients and healthcare systems. Furthermore, the availability of suitable donors and the risk of graft-versus-host disease (GVHD) are significant hurdles in the successful implementation of bone marrow transplants. The market is driven by the increasing prevalence of blood disorders, advancements in transplantation techniques, and improved post-transplant care. Nevertheless, challenges such as high costs, donor availability, and the risk of GVHD need to be addressed for the market's continued growth.
Study Period
2024-2030Base Year
2023CAGR
5.2%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Burgeoning the prevalence of blood-related diseases, such as leukemia and lymphoma is expected to boost the demand for bone marrow transplant market. These diseases require intensive treatment, and in many cases, bone marrow transplantation offers a potentially curative option. The rising incidence of these disorders globally has created a growing demand for bone marrow transplants. Furthermore, advancements in medical research and technology have improved the success rates and outcomes of these procedures, making them an attractive treatment choice. As a result, the increasing prevalence of blood-related diseases are propelling the growth.
By Type
By Treatment Type
By End User
By Geography
The global bone marrow transplant market size was valued at US$ 10.28 billion in 2023 and is projected to grow at a CAGR of 5.2% from 2024-2030.
The growth of the global bone marrow transplant market is driven by factors such as the increasing prevalence of blood disorders and cancers, advancements in transplantation techniques, improved post-transplant care, and a growing focus on personalized medicine and targeted therapies.
North America and Europe have traditionally been the dominant markets for bone marrow transplants. However, the Asia Pacific region is expected to witness significant growth in the coming years due to increasing healthcare infrastructure, rising prevalence of blood disorders, and improving access to transplantation facilities.
1.Executive Summary |
2.Global Bone Marrow Transplant Market Introduction |
2.1.Global Bone Marrow Transplant Market - Taxonomy |
2.2.Global Bone Marrow Transplant Market - Definitions |
2.2.1.Type |
2.2.2.Treatment Type |
2.2.3.End User |
2.2.4.Region |
3.Global Bone Marrow Transplant Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Bone Marrow Transplant Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Bone Marrow Transplant Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Autologous Transplant |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Allogenic Transplant |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Others |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Bone Marrow Transplant Market By Treatment Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Leukemia |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Lymphoma |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Myeloma |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Myelodysplastic Syndrome |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Myeloproliferative Disorders |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Aplastic Anemia |
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Solid Tumors |
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
6.8. Sickle cell Anemia |
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.8.3. Market Opportunity Analysis |
6.9. Thalassemia |
6.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.9.3. Market Opportunity Analysis |
6.10. Others |
6.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.10.3. Market Opportunity Analysis |
7.Global Bone Marrow Transplant Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Multi-specialty Clinics |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Ambulatory Surgical Centers |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Bone Marrow Transplant Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Bone Marrow Transplant Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Autologous Transplant |
9.1.2.Allogenic Transplant |
9.1.3.Others |
9.2. Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Leukemia |
9.2.2.Lymphoma |
9.2.3.Myeloma |
9.2.4.Myelodysplastic Syndrome |
9.2.5.Myeloproliferative Disorders |
9.2.6.Aplastic Anemia |
9.2.7.Solid Tumors |
9.2.8.Sickle cell Anemia |
9.2.9.Thalassemia |
9.2.10.Others |
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Multi-specialty Clinics |
9.3.3.Ambulatory Surgical Centers |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Bone Marrow Transplant Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Autologous Transplant |
10.1.2.Allogenic Transplant |
10.1.3.Others |
10.2. Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Leukemia |
10.2.2.Lymphoma |
10.2.3.Myeloma |
10.2.4.Myelodysplastic Syndrome |
10.2.5.Myeloproliferative Disorders |
10.2.6.Aplastic Anemia |
10.2.7.Solid Tumors |
10.2.8.Sickle cell Anemia |
10.2.9.Thalassemia |
10.2.10.Others |
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Multi-specialty Clinics |
10.3.3.Ambulatory Surgical Centers |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Bone Marrow Transplant Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Autologous Transplant |
11.1.2.Allogenic Transplant |
11.1.3.Others |
11.2. Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Leukemia |
11.2.2.Lymphoma |
11.2.3.Myeloma |
11.2.4.Myelodysplastic Syndrome |
11.2.5.Myeloproliferative Disorders |
11.2.6.Aplastic Anemia |
11.2.7.Solid Tumors |
11.2.8.Sickle cell Anemia |
11.2.9.Thalassemia |
11.2.10.Others |
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Multi-specialty Clinics |
11.3.3.Ambulatory Surgical Centers |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Bone Marrow Transplant Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Autologous Transplant |
12.1.2.Allogenic Transplant |
12.1.3.Others |
12.2. Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Leukemia |
12.2.2.Lymphoma |
12.2.3.Myeloma |
12.2.4.Myelodysplastic Syndrome |
12.2.5.Myeloproliferative Disorders |
12.2.6.Aplastic Anemia |
12.2.7.Solid Tumors |
12.2.8.Sickle cell Anemia |
12.2.9.Thalassemia |
12.2.10.Others |
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Multi-specialty Clinics |
12.3.3.Ambulatory Surgical Centers |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Bone Marrow Transplant Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Autologous Transplant |
13.1.2.Allogenic Transplant |
13.1.3.Others |
13.2. Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Leukemia |
13.2.2.Lymphoma |
13.2.3.Myeloma |
13.2.4.Myelodysplastic Syndrome |
13.2.5.Myeloproliferative Disorders |
13.2.6.Aplastic Anemia |
13.2.7.Solid Tumors |
13.2.8.Sickle cell Anemia |
13.2.9.Thalassemia |
13.2.10.Others |
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Multi-specialty Clinics |
13.3.3.Ambulatory Surgical Centers |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Lonza |
14.2.2.Beike Biotechnology Co., Ltd. |
14.2.3.Mesoblast Ltd |
14.2.4.AllCells |
14.2.5.STEMCELL Technologies Inc. |
14.2.6.Charles River Laboratories |
14.2.7.FUJIFILM Cellular Dynamics, Inc. |
14.2.8.CORESTEM, Inc. |
14.2.9.Gamida Cell |
14.2.10.Merck KgaA |
14.2.11.Sanofi |
15. Research Methodology |
16. Appendix and Abbreviations |